Gene · 4485
Papers4,329
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,061 to 1,080 of 4,329
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Apoptosis Induction, a Sharp Edge of Berberine to Exert Anti-Cancer Effects, Focus on Breast, Lung, and Liver Cancer. | Front Pharmacol | 2022 | 35153781 | PubTator, text mining | PubMed |
| Structures of highly flexible intracellular domain of human α7 nicotinic acetylcholine receptor. | Nat Commun | 2022 | 35145092 | PubTator, text mining | PubMed |
| PHLPP1 deletion restores pancreatic β-cell survival and normoglycemia in the db/db mouse model of obesity-associated diabetes. | Cell Death Discov | 2022 | 35136063 | PubTator, text mining | PubMed |
| MST1 deletion protects β-cells in a mouse model of diabetes. | Nutr Diabetes | 2022 | 35136036 | PubTator, text mining | PubMed |
| Interpretable network-guided epistasis detection. | Gigascience | 2022 | 35134928 | PubTator, text mining | PubMed |
| Mg2+-dependent conformational equilibria in CorA and an integrated view on transport regulation. | Elife | 2022 | 35129435 | PubTator, text mining | PubMed |
| The cGAS-STING signaling in cardiovascular and metabolic diseases: Future novel target option for pharmacotherapy. | Acta Pharm Sin B | 2022 | 35127372 | PubTator, text mining | PubMed |
| Preliminary evidence for the presence of multiple forms of cell death in diabetes cardiomyopathy. | Acta Pharm Sin B | 2022 | 35127369 | PubTator, text mining | PubMed |
| Targeting PLA2G16, a lipid metabolism gene, by Ginsenoside Compound K to suppress the malignant progression of colorectal cancer. | J Adv Res | 2022 | 35127176 | PubTator, text mining | PubMed |
| Noncanonical HIPPO/MST Signaling via BUB3 and FOXO Drives Pulmonary Vascular Cell Growth and Survival. | Circ Res | 2022 | 35124974 | PubTator, text mining | PubMed |
| The bisphenol A metabolite MBP causes proteome alterations in male Cyprinodon variegatus fish characteristic of estrogenic endocrine disruption. | Environ Pollut | 2022 | 35124124 | PubTator, text mining | PubMed |
| XMU-MP-1 protects heart from ischemia/reperfusion injury in mice through modulating Mst1/AMPK pathway. | Eur J Pharmacol | 2022 | 35123978 | PubTator, text mining | PubMed |
| Rare SLC13A1 variants associate with intervertebral disc disorder highlighting role of sulfate in disc pathology. | Nat Commun | 2022 | 35110524 | PubTator, text mining | PubMed |
| Detecting gene-gene interactions from GWAS using diffusion kernel principal components. | BMC Bioinformatics | 2022 | 35105309 | PubTator, text mining | PubMed |
| RNA-binding protein complex LIN28/MSI2 enhances cancer stem cell-like properties by modulating Hippo-YAP1 signaling and independently of Let-7. | Oncogene | 2022 | 35102250 | PubTator, text mining | PubMed |
| Inherited immunodeficiencies associated with proximal and distal defects in T cell receptor signaling and co-signaling. | Biomed J | 2022 | 35091087 | PubTator, text mining | PubMed |
| MST1/2 inhibitor XMU-MP-1 alleviates the injury induced by ionizing radiation in haematopoietic and intestinal system. | J Cell Mol Med | 2022 | 35088536 | PubTator, text mining | PubMed |
| A novel pyroptosis-related signature predicts prognosis and response to treatment in breast carcinoma. | Aging (Albany NY) | 2022 | 35085103 | PubTator, text mining | PubMed |
| Inactivation of p21-Activated Kinase 2 (Pak2) Inhibits the Development of Nf2-Deficient Tumors by Restricting Downstream Hedgehog and Wnt Signaling. | Mol Cancer Res | 2022 | 35082167 | PubTator, text mining | PubMed |
| Reconstitution of purified membrane protein dimers in lipid nanodiscs with defined stoichiometry and orientation using a split GFP tether. | J Biol Chem | 2022 | 35074428 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4485/papers?page=54